Self‐Driven CuAAC Reaction Catalyzed by Photosensitive Biohybrids Energized by Lactate for Boosting Cancer Immunotherapy
Angewandte Chemie International Edition · 2025
DOI: 10.1002/anie.202425018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2025. Verfasst von Huisi Zhao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy…. Hauptthemen laut MEDLINE: Copper, Immunotherapy, Lactic Acid, Neoplasms. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: National Key R&D Program of China, National Natural Science Foundation of China, National Key Research and Development Program of China.
Abstract (Originalsprache)
As a typical bioorthogonal reaction, the copper (I) catalyzed azide‐alkyne 1,3‐cycloaddition (CuAAC) reaction strongly depends on the reducing agents and the rate of the CuAAC reaction is far from sufficient to produce drug agents under physiological conditions. It is necessary and highly demanding to develop an efficient CuAAC reaction without using chemical reducing agents. Herein, inspired by the extracellular electron transfer (EET) mechanisms of the electroactive bacteria within the realm of synthetic biology, a photo‐assisted targeting electroactive bacteria equipped bioorthogonal catalyst system for boosting cancer immunotherapy is constructed. The bacteria specifically anaerobically catabolize lactate at the tumor site, accompanied by transferring electrons to the bioorthogonal catalyst, thereby triggering the CuAAC reaction to produce active drugs in situ. Strikingly, under illumination, the photoelectrons generated by attached AuNPs can be transported into bacterial cytoplasm to accelerate the CuAAC reaction by promoting cellular metabolism. The biohybrid enables synergistic immunogenic cell death (ICD), immune checkpoint blockade (ICB) immunotherapy and alleviation of immunosuppressive microenvironment. Ingeniously, ICD and lactate consumption both boost the efficacy of ICB immunotherapy. Overall, the system provides a bridge between the tumor metabolism and CuAAC reaction through bacterial respiration, offering fascinating opportunities for controlled synthesis of active molecules by bioorthogonal catalysis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Chemical Biology and State Key Laboratory of Rare Earth Resource Utilization, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun, Jilin, 130022, P. R. China.
- University of Science and Technology of China, Hefei, Anhui, 230026, P. R. China.
ORCID-Profile: Xiaogang Qu
Förderung
- National Key R&D Program of China
- National Natural Science Foundation of China
- National Key Research and Development Program of China
Zitieren
APA
Zhao, H., Zhang, Y., Sun, Y., Zhu, Z., Ren, J., & Qu, X. (2025). Self‐Driven CuAAC Reaction Catalyzed by Photosensitive Biohybrids Energized by Lactate for Boosting Cancer Immunotherapy. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202425018
Vancouver
Zhao H, Zhang Y, Sun Y, Zhu Z, Ren J, Qu X. Self‐Driven CuAAC Reaction Catalyzed by Photosensitive Biohybrids Energized by Lactate for Boosting Cancer Immunotherapy. Angewandte Chemie International Edition. 2025. doi:10.1002/anie.202425018
BibTeX
@article{Zhao2025,
author = {Zhao, Huisi and Zhang, Yu and Sun, Yue and Zhu, Zitong and Ren, Jinsong and Qu, Xiaogang},
title = {Self‐Driven CuAAC Reaction Catalyzed by Photosensitive Biohybrids Energized by Lactate for Boosting Cancer Immunotherapy},
journal = {Angewandte Chemie International Edition},
year = {2025},
doi = {10.1002/anie.202425018}
}
EUVIMED